Characterization of the safety profile of trastuzumab deruxtecan by dose: a pooled analysis across DESTINY studies
按剂量划分的曲妥珠单抗德鲁西替康安全性特征:DESTINY 研究的汇总分析
期刊:Oncologist
影响因子:4.2
doi:10.1093/oncolo/oyaf396
Park, Yeon Hee; Cortes, Javier; Modi, Shanu; Hurvitz, Sara A; Bianchini, Giampaolo; Iwata, Hiroji; Shitara, Kohei; Siena, Salvatore; Goto, Yasushi; Ku, Geoffrey Y; Powell, Charles A; Swain, Sandra M; Arunachalam, Meena; Janek, Martin; Cheng, Yingkai; Chu, Changan; Verma, Purnima; Kuptsova-Clarkson, Nataliya; Mathias, Elton; Goodman, Erin; Rugo, Hope S